Astonea Labs Share News - Latest Updates, Live News & More

Latest news about Astonea Labs

Astonea Labs Limited Confirms Non-Applicability of SEBI Large Corporate Framework Apr 29, 2026

Astonea Labs Limited has notified BSE that it does not qualify as a Large Corporate under SEBI's debt securities framework. The company reported outstanding borrowings of Rs. 23.96 crore as of March 31, 2026, excluding short-term debt. The declaration, signed by Company Secretary Ankit Kapoor and CFO Sumit Kumar on April 29, 2026, ensures compliance with multiple SEBI circulars governing large corporate debt issuances and confirms the company's exemption from the Large Corporate classification criteria.

Astonea Labs Limited Submits Quarterly Compliance Certificate for Q4FY26 Apr 09, 2026

Astonea Labs Completes ₹6.25 Crore Acquisition of 25.74% Stake in Damaira Pharmaceuticals Apr 01, 2026

Astonea Labs Adopts New Articles of Association at March 27 EGM Mar 28, 2026

Astonea Labs Board Approves IPO Proceeds Variation and Related Party Transactions Worth Rs. 415 Crore Feb 27, 2026

More news about Astonea Labs

26Jan 26

Astonea Labs Limited Incorporates Wholly-Owned US Subsidiary for Pharmaceutical Business Expansion

Astonea Labs Limited has incorporated Astonea LLC, a wholly-owned foreign subsidiary in Wyoming, USA on 25th January, 2026. The subsidiary will focus on pharmaceuticals, food supplements and cosmetics business, with Astonea Labs holding 100% ownership through cash subscription. The incorporation complies with SEBI regulations and establishes the company's presence in the US market for its core business activities.

11Nov 25

Astonea Labs Reports Strong Half-Year Results and Appoints Three New Directors

Astonea Labs Limited announced unaudited financial results for H1 2025, showing a 40.20% year-over-year increase in revenue from operations to Rs 66.29 crores. The company appointed three new Non-Executive, Non-Independent Directors: Mr. Arun Kumar Tripathi, Mr. Pardeep Dalal, and Mr. Vikrant, effective November 10, 2025, subject to shareholder approval. The board also authorized Ms. Pooja Singh to finalize a revised distribution agreement with Astonea One Private Limited.

20Sept 25

Astonea Labs' Company Secretary Resigns, Trading Window to Close

Astonea Labs Limited reported significant corporate changes. Vijay Kumar, Company Secretary and Compliance Officer, resigned effective September 20, 2025. The company also announced the closure of its trading window from October 1, 2025, for insiders and related parties, in compliance with SEBI regulations. This closure will remain until 48 hours after the declaration of Un-Audited Financial Results for the half-year ending September 30, 2025.

Astonea Labs

171.50

0.0

(0.0%)

1 Year Returns:+26.43%

Industry Peers

Sun Pharmaceutical

1,845.40

(+1.13%)

Divis Laboratories

6,831.50

(+0.52%)

Torrent Pharmaceuticals

4,332.00

(+0.84%)

Cipla

1,413.40

(+6.46%)

Dr Reddys Laboratories

1,263.60

(-0.13%)

Lupin

2,246.80

(+1.41%)

Mankind Pharma

2,423.30

(+0.65%)

Zydus Life Science

975.85

(+3.90%)

Aurobindo Pharma

1,502.80

(+0.35%)

Laurus Labs

1,298.00

(+1.37%)

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104